NCT02732587View on ClinicalTrials.gov

Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

March 15, 2016

Study Completion Date

March 23, 2016

Conditions
Alcohol Drinking
Interventions
DRUG

Saracatinib

Subjects will receive 125 mg Saracatinib for 8-11 days followed by an alcohol interaction lab session

Trial Locations (1)

06519

CMHC, Substance Abuse Center, New Haven

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT02732587 - Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers | Biotech Hunter | Biotech Hunter